Literature DB >> 6476370

Quantitation of type I and III collagens using electrophoresis of alpha chains and cyanogen bromide peptides.

D Chan, W G Cole.   

Abstract

The methods of quantitating the relative amounts of type I and III collagens in samples containing crosslinked collagen chains were evaluated using electrophoresis of alpha chains and cyanogen bromide peptides. The densitometry areas of the alpha I(I) chains from type I collagen and the alpha I(III) chains from type III collagen were reduced because of the failure of the crosslinked chains to dissociate. However, the ratios of the unit densitometry areas of these chains (area of chain/micrograms type I or III collagen loaded) were constant for type I and III collagens prepared from the same samples of tissue. A calibration factor, which was the same for dermis and mitral valve, was derived to convert the densitometry area ratios to the weight ratios of type I to III collagens. In contrast, the densitometry areas of the alpha I(I) CB8 (type I collagen marker) and the alpha I(III) CB5 (type III collagen marker) were not reduced by crosslinked collagen chains. A calibration factor was also derived to convert the ratios of the densitometry areas of the marker peptides to weight ratios of type I to type III collagens. Almost identical results were obtained when electrophoresis of alpha chains and of cyanogen bromide peptides was used with these calibration factors to quantitate the relative amounts of type I and III collagens in tissue extracts which contained different amounts of crosslinked chains.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476370     DOI: 10.1016/0003-2697(84)90012-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

2.  Changes in collagen and elastin in rabbit right-ventricular pressure overload.

Authors:  R B Low; W S Stirewalt; P Hultgren; E S Low; B Starcher
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

3.  In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds.

Authors:  F X Maquart; G Bellon; B Chaqour; J Wegrowski; L M Patt; R E Trachy; J C Monboisse; F Chastang; P Birembaut; P Gillery
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

4.  [Quantitative polarization microscopy demonstration of collagen type I and type III in histologic paraffin sections].

Authors:  S Ogbuihi; Z Müller; P Zink
Journal:  Z Rechtsmed       Date:  1988

5.  Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair.

Authors:  Daniela Ulrich; Sharon Lee Edwards; Kai Su; Ker Sin Tan; Jacinta F White; John A M Ramshaw; Camden Lo; Anna Rosamilia; Jerome A Werkmeister; Caroline E Gargett
Journal:  Tissue Eng Part A       Date:  2013-11-21       Impact factor: 3.845

6.  Regional variation in tissue composition and biomechanical properties of postmenopausal ovine and human vagina.

Authors:  Daniela Ulrich; Sharon L Edwards; Vincent Letouzey; Kai Su; Jacinta F White; Anna Rosamilia; Caroline E Gargett; Jerome A Werkmeister
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

7.  Influence of reproductive status on tissue composition and biomechanical properties of ovine vagina.

Authors:  Daniela Ulrich; Sharon L Edwards; Kai Su; Jacinta F White; John A M Ramshaw; Graham Jenkin; Jan Deprest; Anna Rosamilia; Jerome A Werkmeister; Caroline E Gargett
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

8.  Lentivirus-mediated ERK2 siRNA reduces joint capsule fibrosis in a rat model of post-traumatic joint contracture.

Authors:  Fengfeng Li; Shen Liu; Cunyi Fan
Journal:  Int J Mol Sci       Date:  2013-10-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.